loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Montelukast

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales Montelukast sodium

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Montelukast

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,134Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IntelGenx Reports Preliminary Results For Montelukast VersaFilm In Alzheimer's
    IntelGenx Reports Preliminary Results For Montelukast VersaFilm In Alzheimer's

    03 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/03/2908117/0/en/IntelGenx-Obtains-Preliminary-Efficacy-Results-for-the-BUENA-Montelukast-VersaFilm-Phase-2a-Clinical-Trial-in-Patients-with-Mild-to-Moderate-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    03 Jul 2024
    Share Share
    New York attorney general urges stronger safety warning on asthma drug Singulair
    New York attorney general urges stronger safety warning on asthma drug Singulair

    23 Feb 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/new-york-attorney-general-urges-stronger-safety-warning-asthma-drug-singulair-2024-02-23/

    REUTERS
    23 Feb 2024
    Share Share
    Enforcement Report - Week of November 15, 2023
    Enforcement Report - Week of November 15, 2023

    15 Nov 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-15-2023-17266.pdf

    FDA
    15 Nov 2023
    Share Share
    Merck accused of downplaying early evidence of drug’s brain impact
    Merck accused of downplaying early evidence of drug’s brain impact

    27 Jun 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/merck-accused-downplaying-early-evidence-drugs-brain-impact-2023-06-26/

    REUTERS
    27 Jun 2023
    Share Share
    Health Canada Issues Recall of Pro Doc Ltée's Montelukast chewable tablet; Out of specification
    Health Canada Issues Recall of Pro Doc Ltée's Montelukast chewable tablet; Out of specification

    12 May 2023

    // HEALTH CANADA

    https://recalls-rappels.canada.ca/en/alert-recall/montelukast-chewable-tablet-out-specification

    HEALTH CANADA
    12 May 2023
    Share Share
    Enforcement Report - Week of May 10, 2023
    Enforcement Report - Week of May 10, 2023

    10 May 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-10-2023-12326.pdf

    FDA
    10 May 2023
    Share Share